Platelet serotonergic markers in posttraumatic stress disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 26, Issue 6, 2002, Pages 1193-1198

  Pivac, Nela ^a   Mück Šeler, Dorotea ^a   Šagud, Marina ^b   Jakovljevi, Miro ^b  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b KBC Zagreb   (Croatia)

Author keywords

Blood platelets; Monoamine oxidase; Posttraumatic stress disorder; Prisoners of war; Serotonin; War veterans

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); BIOLOGICAL MARKER; SEROTONIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; MALE; POSTTRAUMATIC STRESS DISORDER; PRISONER; PSYCHOLOGIC ASSESSMENT; RATING SCALE; SCORING SYSTEM; SEROTONINERGIC SYSTEM; SOLDIER; THROMBOCYTE; WAR;

ADULT; BIOLOGICAL MARKERS; BLOOD PLATELETS; CROATIA; DEPRESSIVE DISORDER; HUMANS; MALE; MONOAMINE OXIDASE; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN; STRESS DISORDERS, POST-TRAUMATIC; VETERANS;

EID: 0036776229     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(02)00261-0     Document Type: Article

References (47)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 4th Ed. 1994;American Psychiatric Press, Washington, DC.
2. 2 receptor binding properties and their regulation by endogenous serotonin. Life Sci. 52:1993;313-321.
3. Arora R.C., Fichtner C.G., O'Connor F., Crayton J.W. Paroxetine binding in the blood platelets of posttraumatic stress disorder patients. Life Sci. 53:1993;919-928.
4. Berlin I., Said S., Spreux-Varoquaux O., Olivares R., Launay J.M., Puech A.J. Monoamine oxidase A and B activities in heavy smokers. Biol. Psychiatry. 38:1995;756-761.
5. Brady K., Pearlstein T., Asnis G.M., Baker D., Rothbaum B., Sikes C.R., Farfel G.M. Efficacy and safety of sertraline treatment of posttraumatic stress disorder. JAMA. 283:2000;1837-1844.
6. Camacho A., Dimsdale J.E. Platelets and psychiatry: lessons learned from old and new studies. Psychosom. Med. 62:2000;326-336.
7. Chaouloff F. Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res. Rev. 18:1993;1-32.
8. Čičin-Šain L., Mimica N., Hranilović D., Balija M., Ljubin T., Makarić G., Folnegović-Šmalc V., Jernej B. Posttraumatic stress disorder and platelet serotonin measures. J. Psychiatr. Res. 34:2000;155-161.
9. Davidson J.R.T., Connor K.M. Serotonin and serotonergic drugs in posttraumatic stress disorder. Montgomery S.M., den Boer J.A. SSRIs in Depression and Anxiety. Perspectives in Psychiatry. vol. 7:2001;173-188 Wiley, New York.
10. Davidson J., Lipper S., Kilts C.D., Mahorney S., Hammett E. Platelet MAO activity in posttraumatic stress disorder. Am. J. Psychiatry. 142:1985;1341-1343.
11. Davis L.L., Sarias A., Lambert M.T., Heimberg C., Petty F. Posttraumatic stress disorder and serotonin - new direction for research and treatment. J. Psychiatry Neurosci. 22:1997;318-320.
12. Dinan T.G. Serotonin and the regulation of hypothalamic-pituitary-adrenal axis. Life Sci. 58:1996;1683-1694.
13. Fichtner C.G., O'Connor F.L., Yeoh H.C., Arora R.A., Crayton J.W. Hypodensity of platelet serotonin uptake sites in posttraumatic stress disorder: associated clinical features. Life Sci. 57:1995;37-44.
14. Hamner M.B., Frueh C., Ulmer H.G., Arana G.W. Psychotic features and illness severity in combat related veterans with chronic posttraumatic stress disorder. Biol. Psychiatry. 45:1999;846-852.
15. Henigsberg N., Folnegović-Šmalc V., Moro L.J. Stressor characteristics and post-traumatic stress disorder symptom dimensions in war victims. Croat. Med. J. 42:2001;543-550.
16. Jakovljević M., Mück-Šeler D., Pivac N., Ljubičić D., Bujas M., Dodig G. Seasonal influence on platelet 5-HT levels in patients with recurrent major depression and schizophrenia. Biol. Psychiatry. 41:1997;1028-1034.
17. Kaufman J., Charney D. Comorbidity of mood and anxiety disorders. Depress. Anxiety. 12(Suppl. 1):2000;69-76.
18. Kozarić-Kovačić D., Marušić A., Ljubin T. Combat experienced soldiers and tortured prisoners of war differ in the clinical presentation of posttraumatic stress disorder. Nord. J. Psychiatry. 53:1999;11-15.
19. Kozarić-Kovačić D., Ljubin T., Rutić-Puž L., Mihaljević J., Jernej B., Čičin-Šain L. Platelet monoamine oxidase activity, ego strength, and neuroticism in soldiers with combat related current posttraumatic stress disorder. Croat. Med. J. 41:2000;76-80.
20. Krajl M. A rapid microfluorimetric determination of monoamine oxidase. Biochem. Pharmacol. 14:1965;1683-1685.
21. Lowry O.H., Rosenbrough N.S., Farr A.C., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
22. Maes M., Meltzer H.Y. The serotonin hypothesis of major depression. Bloom F.E., Kupfer D.J. Psychopharmacology: The Fourth Generation of Progress. 1995;933-944 Raven Press, New York.
23. Maes M., Lin A.-H., Verkerk R., Delmeire L., Van Gastel A., Van Der Planken M., Scharpe S. Serotonergic and noradrenergic markers of post-traumatic stress disorder with and without major depression. Neuropsychopharmacology. 20:1999;188-197.
24. Maguire K., Norman T., Burrows G., Hopwood M., Morris P. Platelet paroxetine binding in post-traumatic stress disorder. Psychiatry Res. 77:1998;1-7.
25. Mellman T.A., Kumar A.M. Platelet serotonin measures in posttraumatic stress disorder. Psychiatry Res. 53:1994;99-101.
26. Mendelson S.C. The current status of the platelet 5-HT2A receptor in depression. J. Affect. Disord. 57:2000;13-24.
27. Montgomery S.A., Asperg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry. 134:1979;382-389.
28. Mück-Šeler D., Jakovljević M., Deanović Ž. Platelet serotonin in subtypes of schizophrenia and unipolar depression. Psychiatry Res. 38:1991;105-113.
29. Mück-Šeler D., Jakovljević M., Pivac N. Platelet 5-HT concentrations and suicidal behavior in recurrent major depression. J. Affect. Disord. 39:1996;73-80.
30. Mück-Šeler D., Pivac N., Jakovljević M., Vukušić H., Junaci S. Platelet 5-HT concentration in posttraumatic stress disorder. Psychiatr. Danub. 10:1998;102-103.
31. Mück-Šeler D., Pivac N., Jakovljević M. Sex difference, season of birth and platelet 5-HT levels in schizophrenic patients. J. Neural Transm. 106:1999;337-347.
32. Mück-Šeler D., Pivac N., Jakovljević M., Brzović Z. Platelet serotonin, plasma cortisol, and dexamethasone suppression test in schizophrenic patients. Biol. Psychiatry. 106:1999;337-347.
33. Mück-Šeler D., Pivac N., Jakovljević M., Šagud M., Mihaljević-Peleš A. Platelet 5-HT concentration and comorbid depression in war veterans with or without posttraumatic stress disorder. J. Affect. Disord. 2002;. in press.
34. Newport D.J., Nemeroff C.B. Neurobiology of posttraumatic stress disorder. Curr. Opin. Neurobiol. 10:2000;211-218.
35. Oreland L., Shaskan E.G. Some rationale behind the use of monoamine oxidase activity as a biological marker. Trends Pharmacol. Sci. 4:1983;339-341.
36. Pivac N., Mück-Šeler D., Jakovljević M. Platelet 5-HT levels and hypothalamic-pituitary-adrenal axis in schizophrenic patients with positive and negative symptoms. Neuropsychobiology. 36:1997;19-21.
37. Pivac N., Jakovljević M., Mück-Šeler D., Brzović Z. Hypothalamic-pituitary-adrenal axis function and platelet serotonin concentrations in depressed patients. Psychiatry Res. 73:1997;123-132.
38. Ramsay R. Invited review: posttraumatic stress disorder; a new clinical entity? J. Psychosom. Res. 34:1990;355-365.
39. Schalling D., Asberg M., Edman G., Oreland L. Markers for vulnerability to psychopathology: temperament traits associated with platelet MAO activity. Acta Psychiatr. Scand. 76:1987;172-182.
40. Shalev A.Y. Posttraumatic stress disorder: diagnosis, history and life course. Nutt D., Davidson J.R.T., Zohar J. Posttraumatic Stress Disorder: Diagnosis, Management and Treatment. 2000;1-15 Martin Dunitz, London.
41. Solomon Z., Neria Y., Ohry A., Waysman M., Ginzburg K. PTSD among Israeli former prisoners of war and soldiers with combat stress reaction: a longitudinal study. Am. J. Psychiatry. 151:1994;554-559.
42. Southwick S.M., Krystal J.H., Bremner J.D., Morgan C.A., Nicolaou A.L., Nagy L.M., Johnson D.R., Heninger G.R., Charney D.S. Noradrenergic and serotonergic function in posttraumatic stress disorder. Arch. Gen. Psychiatry. 54:1997;749-758.
43. Spivak B., Vered Y., Graff E., Blum I., Mester R., Weizman A. Low platelet poor plasma concentrations of serotonin in patients with combat-related posttraumatic stress disorder. Biol. Psychiatry. 45:1999;840-845.
44. Stahl S.M. Platelets as pharmacological models for the receptors and biochemistry of monoaminergic neurons. Longenecker G.L. Platelets: Physiology and Pharmacology. 1985;307-340 Academic Press, New York.
45. Stahl S.M. Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects. J. Affect. Disord. 51:1998;215-235.
46. Weathers F.W., Keane T.M., Davidson J.R.T. Clinician-administered PTSD scale: a review of the first ten years of research. Depress. Anxiety. 13:2001;132-156.
47. Zohar J., Mueller E.A., Insel T.R., Zohar-Kadonch R., Murphy D. Serotonergic responsivity in obsessive-compulsive disorder. Arch. Gen. Psychiatry. 44:1987;946-951.